Document Detail

Hair Cortisol Measurement in Mitotane-Treated Adrenocortical Cancer Patients.
MedLine Citation:
PMID:  24627099     Owner:  NLM     Status:  Publisher    
The only approved drug for the treatment of adrenocortical cancer (ACC) is mitotane. Mitotane is adrenolytic and therefore, hydrocortisone replacement therapy is necessary. Since mitotane increases cortisol binding globulin (CBG) and induces CYP3A4 activity, high doses of hydrocortisone are thought to be required. Evaluation of hydrocortisone therapy in mitotane-treated patients has been difficult since there is no good marker to evaluate hydrocortisone therapy. Measurement of cortisol in scalp hair is a novel method that offers the opportunity to measure long-term cortisol levels. Our aim was to evaluate whether hair cortisol measurements could be useful in evaluating recent hydrocortisone treatment in mitotane-treated ACC patients. Hair cortisol levels were measured in 15 mitotane-treated ACC patients on hydrocortisone substitution and 96 healthy individuals. Cortisol levels were measured in 3 cm hair segments, corresponding to a period of 3 months. Hair cortisol levels were higher in ACC patients compared to healthy individuals (p<0.0001). Seven ACC patients (47%) had hair cortisol levels above the reference range. None of the patients had hair cortisol levels below normal. In contrast to hydrocortisone doses (β=0.03, p=0.93), hair cortisol levels were associated with BMI (β=0.53, p=0.042). There was no correlation between hair cortisol levels and hydrocortisone doses (β=0.41, p=0.13). Almost half of the ACC patients had high hair cortisol levels, suggesting long-term over-substitution of hydrocortisone in some of the patients, whereas none of the patients was under-substituted. Hair cortisol measurements might be useful in long-term monitoring hydrocortisone treatment in mitotane-treated ACC patients.
L Manenschijn; M Quinkler; E F C van Rossum
Related Documents :
24765879 - Serum specific ige: a biomarker of response to allergen immunotherapy.
24355069 - Endocrine autoimmunity in turner syndrome.
11558109 - Impaired function of neutrophils in uraemic patients.
24916929 - Total ige and eotaxin (ccl11) contents in tears of patients suffering from seasonal all...
24262509 - Renal interstitial infiltration and tertiary lymphoid organ neogenesis in iga nephropathy.
24168079 - High dose droperidol and qt prolongation: analysis of continuous 12-lead recordings.
4047279 - Fenestrated capillaries in human parietal and rabbit diaphragmatic peritoneum.
11762609 - Mixed connective tissue disease--clinical and immunological profile.
24357039 - Hashimoto's encephalopathy: south korean experiences.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-3-13
Journal Detail:
Title:  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme     Volume:  -     ISSN:  1439-4286     ISO Abbreviation:  Horm. Metab. Res.     Publication Date:  2014 Mar 
Date Detail:
Created Date:  2014-3-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0177722     Medline TA:  Horm Metab Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© Georg Thieme Verlag KG Stuttgart · New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Acute Post-Exercise Oxygen Uptake, Hormone and Plasma Metabolite Response in Obese Men.
Next Document:  Extracellular Visfatin Activates Gluconeogenesis in HepG2 Cells Through the Classical PKA/CREB-Depen...